Xenon Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
November 08 2017 - 4:01PM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage
biopharmaceutical company, today announced that Dr. Simon Pimstone,
Xenon's President and Chief Executive Officer, will present a
corporate update at the Stifel 2017 Healthcare Conference in New
York, NY on Tuesday, November 14, 2017 at 2:00 pm ET.
A live audio webcast of the presentation will be
available on the investors section of Xenon's website at
www.xenon-pharma.com and will be available for replay following the
event.
About Xenon Pharmaceuticals Inc.
Xenon is a clinical stage biopharmaceutical
company focused on developing innovative therapeutics to improve
the lives of patients with neurological disorders. Building upon
our extensive knowledge of human genetics and diseases caused by
mutations in ion channels, known as channelopathies, we are
advancing – both independently and with our pharmaceutical
collaborators – a novel product pipeline of ion channel modulators
to address therapeutic areas of high unmet medical need, such as
pain and epilepsy. For more information, please visit
www.xenon-pharma.com.
Investor/Media Contact:Jodi Regts VP, Corporate
Affairs & Investor Relations Xenon Pharmaceuticals Inc. Phone:
604.484.3353 Email: investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2024 to May 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From May 2023 to May 2024